1. High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. Issue 16 (2nd June 2019) Authors: Hollis, Robert L.; Churchman, Michael; Michie, Caroline O.; Rye, Tzyvia; Knight, Laura; McCavigan, Andrena; Perren, Timothy; Williams, Alistair R. W.; McCluggage, W. Glenn; Kaplan, Richard S.; Jayson, Gordon C.; Oza, Amit; Harkin, D. Paul; Herrington, C. Simon; Kennedy, Richard; Gourley, Charlie Journal: Cancer Issue: Volume 125:Issue 16(2019) Page Start: 2772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial. Issue 1 (1st January 2016) Authors: You, Benoit; Deng, Wei; Hénin, Emilie; Oza, Amit; Osborne, Raymond Journal: International journal of gynecological cancer Issue: Volume 26:Issue 1(2016) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma. (1st November 2014) Authors: Ledermann, Jonathan A.; Luvero, Daniela; Shafer, Aaron; O'Connor, Dennis; Mangili, Giorgia; Friedlander, Michael; Pfisterer, Jacobus; Mirza, Mansoor R.; Kim, Jae-Weon; Alexandre, Jerome; Oza, Amit; Brown, Jubilee Journal: International journal of gynecological cancer Issue: Volume 24(2014)Supplement 3 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary. (1st November 2014) Authors: Okamoto, Aikou; Glasspool, Rosalind M.; Mabuchi, Seiji; Matsumura, Noriomi; Nomura, Hiroyuki; Itamochi, Hiroaki; Takano, Masashi; Takano, Tadao; Susumu, Nobuyuki; Aoki, Daisuke; Konishi, Ikuo; Covens, Alan; Ledermann, Jonathan; Mezzazanica, Delia; Steer, Christopher; Millan, David; McNeish, Iain ... Journal: International journal of gynecological cancer Issue: Volume 24(2014)Supplement 3 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Prevent Ovarian Cancer Program (POCP): Identification of Women at Risk for Ovarian Cancer Using Complementary Recruitment Approaches. Issue 8 (August 2021) Authors: Tone, Alicia A.; McCuaig, Jeanna M.; Ricker, Nicole; Boghosian, Talin; Romagnuolo, Tina; Stickle, Natalie; Virtanen, Carl; Zhang, Tong; Kim, Raymond H.; Ferguson, Sarah E.; May, Taymaa; Laframboise, Stephane; Armel, Susan; Demsky, Rochelle; Volenik, Alexandra; Stuart-McEwan, Terri; Shaw, Patricia... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers. (4th December 2020) Authors: Banerjee, Susana; Oaknin, Ana; Sanchez-Simon, Inmaculada; Salgado, Alfonso Cortes; Patel, Sandip Pravin; Oza, Amit; Das, Mayukh; Kourtesis, Panagiotis; Ascierto, Maria Libera; Diamond, Jennifer R Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer. (1st November 2009) Authors: Friedlander, Michael; Butow, Phyllis; Stockler, Martin; Gainford, Corona; Martyn, Julie; Oza, Amit; Donovan, Heidi S.; Miller, Brigitte; King, Madeline Journal: International journal of gynecological cancer Issue: Volume 19(2009)Supplement 2 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Conservative management of adnexal masses. Issue 3 (March 2019) Authors: May, Taymaa; Oza, Amit Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Prevent Ovarian Cancer Program (POCP): Identification of Women at Risk for Ovarian Cancer Using Complementary Recruitment Approaches. Issue 8 (August 2021) Authors: Tone, Alicia A.; McCuaig, Jeanna M.; Ricker, Nicole; Boghosian, Talin; Romagnuolo, Tina; Stickle, Natalie; Virtanen, Carl; Zhang, Tong; Kim, Raymond H.; Ferguson, Sarah E.; May, Taymaa; Laframboise, Stephane; Armel, Susan; Demsky, Rochelle; Volenik, Alexandra; Stuart-McEwan, Terri; Shaw, Patricia... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 8(2021) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The role of cediranib in ovarian cancer: current status and further investigation. (2nd August 2016) Authors: Ethier, Josee-Lyne; Lheureux, Stephanie; Oza, Amit Journal: Expert opinion on orphan drugs Issue: Volume 4:Number 8(2016:Aug.) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗